The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice

Virology

Volumn 258, Issue 2, 1999, Pages 282-294

  Parr, Margaret B ^a   Parr, Earl L ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX VIRUS 2; IMMUNITY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERFERON PRODUCTION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VAGINA MUCOSA; VAGINA SECRETION; VAGINITIS;

EID: 0033526515     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9739     Document Type: Article

References (58)

1. Babiuk L. A., Rouse B. T. Immune interferon production by lymphoid cells: Role in the inhibition of herpesviruses. Infect. Immun. 13:1976;1567-1578.
2. Baron J. L., Madri J. A., Ruddle N. H., Hashim G., Janeway C. A. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:1993;57-68.
3. Basham T. Y., Nickoloff B. J., Merigan T. C., Morhenn V. B. Recombinant gamma interferon differentially regulates class II antigen expression and biosynthesis on cultured normal human keratinocytes. J. Interferon Res. 5:1985;23-32.
4. Baumgarth N., Kelso A. In vivo blockade of gamma interferon affects the influenza virus-induced humoral and the focal cellular immune response in lung tissue. J. Virol. 70:1996;4411-4418.
5. Bevilacqua M. P. Endothelial-leukocyte adhesion molecules. Annu. Rev. Immunol. 11:1993;767-804.
6. Billiau A. Interferon-γ: Biology and role in pathogenesis. Dixon F. J. Advances in Immunology. 1996;61-130 Academic Press, New York.
7. Bland P. MHC class II expression by the gut epithelium. Immunol. Today. 9:1988;174-178.
8. Bot A., Bot S., Bona C. A. Protective role of gamma interferon during the recall response to influenza virus. J. Virol. 72:1998;6637-6645.
9. Buchmeier N. A., Schreiber R. D. Requirement of endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc. Natl. Acad. Sci. USA. 82:1985;7404-7408.
10. Cantin E. M., Hinton D. R., Chen J., Openshaw H. Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69:1995;4898-4905.
11. Chisholm P. L., Williams C. A., Lobb R. R. Monoclonal antibodies to the integrin α-4 subunit inhibit the murine contact hypersensitivity response. Eur. J. Immunol. 23:1993;682-688.
12. Croen K. D. Nitric oxide and herpes simplex virus1 replication. J. Clin. Invest. 91:1993;2446-2452.
13. Dijkmans R., Billiau A. Interferon γ: A master key in the immune system. Curr. Opin. Immunol. 1:1988;269-274.
14. Dustin M. L., Rothlein R., Bhan A. K., Dinarello C. A., Springer T. A. Induction by IL 1 and interferon-γ, tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137:1986;245-253.
15. Dustin M. L., Springer T. A. Lymphocyte function associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least 3 mechanisms for lymphocyte adhesion to cultured endothelial cells. J. Cell Biol. 107:1988;321-326.
16. Farrar M. A., Schreiber R. D. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11:1993;571-611.
17. Franco M. A., Greenberg H. B. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J. Virol. 69:1995;7800-7806.
18. Issekutz T. B. Dual inhibition of VLA-4 and LFA-1 maximally inhibits cutaneous delayed type hypersensitity induced inflammation. Am. J. Pathol. 143:1993;1285-1293.
19. Issekutz T. B., Stoltz J. M., Meide P. v. d. Lymphocyte recruitment in delayed-type hypersensitivity. J. Immunol. 140:1988;2989-2993.
20. Karupiah G., Xie Q., Buller R. M. L., Nathan C., Duarte C., Mac Micking J. D. Inhibition of viral replication by interferon-γ induced nitric oxide synthase. Science. 261:1993;1445-1448.
21. King N. J. C., Parr E. L., Parr M. B. Migration of lymphoid cells from vaginal epithelium to the iliac lymph nodes in relation to vaginal infection by herpes simplex virus type 2. J. Immunol. 160:1998;1173-1180.
22. Kornbluth R. S., Oh P. S., Munis J. R., Cleveland P. H., Richman D. D. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169:1989;1137-1151.
23. Koyanagi Y., O'Brien W. A., Zhao J. Q., Golde D. W., Gasson J. C., Chen I. S. Y. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science. 241:1988;1673-1675.
24. Lechleitner S., Gille J., Johnson D. R., Petzelbauer P. Interferon enhances tumor necrosis factor-induced vascular cell adhesion molecule 1 (CD106) expression in human endothelial cells by an interferon-related factor 1-dependent pathway. J. Exp Med. 187:1998;2023-2030.
25. Li H., Jerrells T. R., Spitalny G. L., Walker D. H. Gamma interferon as a crucial host defense against Rickettsia conorri in vivo. Infect. Immun. 55:1987;1252-1255.
26. Lohman B. L., Miller C. J., McChesney M. B. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J. Immunol. 155:1995;5855-5860.
27. Mackay C. R. T cell memory: The connection between function, phenotype, and migration pathways. Immunol. Today. 12:1991;189-192.
28. Mackay C. R. The concept of memory T cells. Snow E. C. Handbook of B and T Lymphocytes. 1994;159-177 Academic Press, New York.
29. Mackay C. R., Marston W. L., Dudler L., Spertini O., Tedder T. F., Hein W. R. Tissue-specific migration pathways by phenotypically distinct subpopulations of memory T cells. Eur. J. Immunol. 22:1992;887-895.
30. McDermott M. R., Brais P. L. J., Goettsche G. C., Evelegh M. J., Goldsmith C. H. Expression of immunity to intravaginal herpes simplex virus type 2 infection in the genital tract and associated lymph nodes. Arch. Virol. 93:1987;51-68.
31. McDermott M. R., Smiley B. J., Brais P. L. J., Rudzroga H., Bienenstock J. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J. Virol. 51:1984;247-253.
32. Mestan J., Brockhaus M., Kirchner H., Jacobsen H. Antiviral activity of tumour necrosis factor. Synergism with interferons and induction of oligo-2′, 5′-adenylate synthetase. J. Gen. Virol. 69:1988;3113-3120.
33. Milligan G. N., Bernstein D. I. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology. 212:1995;481-489.
34. Milligan G. N., Bernstein D. I. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virol. 229:1997;259-268.
35. Milligan G. N., Bernstein D. I., Bourne N. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J. Immunol. 160:1998;6093-6100.
36. Munro J. M., Pober J. S., Cotran R. S. Tumor necrosis factor and interferon-γ induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of papio anubis. Am. J. Pathol. 135:1989;121-133.
37. Murali-Krishna K., Altman J. D., Suresh M., Sourdive D. J. D., Zajac A. J., Miller J. D., Slansky J., Ahmed R. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity. 8:1998;177-187.
38. Nathan, C.1992. Interferon and inflammation. InInflammation: Basic Principles and Clinical Correlates (J. I. Gallin, I. M. Goldstein, and R. Synderman, Eds.), pp. 265-290. Raven Press, New York.
39. Parr E. L., Bozzola J. J., Parr M. B. Immunity to vaginal infection by herpes simplex virus type 2 in adult mice: Characterization of the antibody in vaginal mucus. J. Reprod. Immunol. 38:1998;15-30.
40. Parr E. L., Parr M. B. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2. J. Virol. 71:1997;8109-8115.
41. Parr E. L., Parr M. B. Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2. J. Virol. 72:1998a;5137-5145.
42. Parr M. B., Kepple L., McDermott M. R., Drew M. D., Bozzola J. J., Parr E. L. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab. Invest. 70:1994;369-380.
43. Parr M. B., Parr E. L. Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes. J. Virol. 72:1998b;2677-2685.
44. Parr, M. B, and, Parr, E. L. 1999, Female genital tract immunity in animal models, In, Mucosal Immunology, (, P. L. Ogra, M. E. Lamm, J. R. McGhee, J. Mestecky, W. Strober, and J. Bienenstock, Eds.), 2nd ed, Academic Press, San Diego.
45. Perry L. L., Feilzer K., Portis J. L., Caldwell H. D. Distinct homing pathways direct T lymphocytes to the genital and intestinal mucosae in Chlamydia-infected mice. J. Immunol. 160:1998;2905-2914.
46. Picker L. J., Butcher E. C. Physiological and molecular mechanisms of lymphocyte homing. Annu. Rev. Immunol. 10:1992;561-591.
47. Pober J. S., Gimbrone M. A. J., Cotran R. S., Reiss C. S., Burakoff S. J., Fiers W., Ault K. A. Ia expression by vascular endothelium is inducible by activated T cells and by human γ-interferon. J. Exp. Med. 157:1983;1339-1351.
48. Ramsay A. J., Ruby J., Ramshaw I. A. A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today. 14:1993;155-157.
49. Ruszczak Z., Detmar M., Imcke E., Orfanos C. E. Effects of rIFN alpha, beta, and gamma on the morphology, proliferation and cell surface antigen expression of human dermal microvascular endothelial cells in vitro. J. Invest. Dermatol. 95:1990;693-699.
50. Scheynius A., Camp R. L., Pure E. Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1. J. Immunol. 150:1993;655-663.
51. Springer T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration. The multi-step paradigm. Cell. 76:1994;301-314.
52. Squires K. E., Schreiber R. D., McElrath M. J., Rubin B. Y., Anderson S. L., Murray H. W. Experimental visceral leishmaniasis: Role of endogenous IFN-γ in host defense and tissue granulomatous response. J. Immunol. 143:1989;4244-4249.
53. Steeg P. S., Johnson H. M., Oppenheim J. J. Regulation of murine macrophage Ia antigen expression by an immune interferon-like lymphokine: Inhibitory effect of endotoxin. J. Immunol. 129:1982;2402.
54. Suzuki Y., Orellana M. A., Schreiber R. D., Semington J. S. Interferon-γ: The major mediator of resistance against Toxoplasma gondii. Science. 240:1988;516-518.
55. Valle M. J., Bobrove A. M., Strober S., Merigan T. C. Immune specific production of interferon by human T cells in combined macrophage-lymphocyte cultures in response to herpes simplex antigen. J. Immunol. 114:1975;435-441.
56. Wellicome S. M., Thornhill M. H., Pitzalis C., Thomas D. S., Lanchbury J. S. S., Panayi G. S., Haskard D. O. A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1 or lipopolysaccharide. J. Immunol. 144:1990;2558-2565.
57. Yu C.-L., Haskard D. O., Cavender D., Johnson A. R., Ziff M. Human gamma interferon increases the binding of T lymphocytes to endothelial cells. Clin. Exp. Immunol. 62:1985;554-560.
58. Zhong G., Peterson E. M., Czarniecki C. W., Schreiber R. D., de la Maza L. M. Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections. Infect. Immun. 57:1989;152-157.